	Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study. Ther Adv Neurol Disord Oreja-Guevara C, Gómez-Estévez I, Agüado García L, Martín Martínez J, Gómez Gutiérrez M, Gascón Giménez F, Agüera Morales E, Meca-Lallana V, Barrero Hernández FJ, González Quintanilla V, Romero Pinel L, Delgado Gil V, Durán Ferreras E, Blasco Quílez R, Meca-Lallana J, Landete Pascual L, Aladro-Benito Y, Boyero Durán S, Gracia Gil J, Caminero Rodríguez AB, Cano Orgaz AT, Eichau Madueño S, Querol Pascual MR, Otano Martínez M, Alonso Torres AM, Calles Hernández C, López Real A, Ares Luque A, Lorenzo González JR, Gómez Vicente L, Díaz Sánchez M. PMID: 42602134 [PubMed]
	Exploratory multi-omics analysis suggests context-dependent immune responses to vitamin D(3) supplementation in PBMCs of multiple sclerosis patients. Front Immunol Tripathi T, Gospodarska E, Geran R, Sperber PS, Schmitz-Hübsch T, Paul F, Carlberg C. PMID: 42601952 [PubMed - indexed for MEDLINE]
	Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data. J Neurol Neurosurg Psychiatry Zhu C, Vukusic S, Kalincik T, Mathey G, Kermode AG, Maillart E, Lechner-Scott J, Le Page E, Roos I, Ciron J, Kubala Havrdova E, Horakova D, De Sèze J, Skibina O, Ruet A, Yetkin MF, Labauge P, Habek M, Kwiatkowski A, Baghbanian SM, Zephir H, Meca-Lallana JE, Valero López G, Papeix C, Gerlach O, Defer G, Fabis-Pedrini M, Carroll WM, Lebrun-Frenay C, Hodgkinson S, Moreau T, Laureys G, Laplaud DA, Prat A, Berger E, Lapointe E, Clavelou P, Ampapa R, Thouvenot E, Stetkarova I, Heinzlef O, Stourac P, Pelletier J, Foschi M, Al Khedr A, D'Amico E, Casez O, Alroughani R, Bourre B, Brecl Jakob G, Creange A, Ozakbas S, David T, John N, Magy L, Camdessanché JP, Moulin S, Doghri I, Sarov Riviere M, Hankiewicz K, Pottier C, Manchon E, Aboab J, Tchikviladze M, Nifle C, Merlo D, Monif M, Zhou Z, Foong YC, Jokubaitis V, van der Walt A, Butzkueven H, OFSEP and MSBase investigators. PMID: 42601218 [PubMed - as supplied by publisher]
	PARP inhibition attenuates neuroinflammation and demyelination in a rat model of multiple sclerosis: A longitudinal [(11)C]PBR28 TSPO PET imaging study. Neurotherapeutics Li G, Antunes IF, Ming Z, Wu C, Cornelissen B, de Vries EF. PMID: 42600545 [PubMed - as supplied by publisher]
	Natural flavonoids in multiple sclerosis: molecular insights and emerging therapeutic strategies. Front Immunol Abusaliya A, Al Shamsi M, Orsud H, Al Rasbi Z, Zoughbor S, Joher N. PMID: 42597552 [PubMed - indexed for MEDLINE]
	Genetic Algorithm-Optimized support vector machine for MRI-based multiple sclerosis diagnosis from white matter lesion features. Digit Health Hosseiny RS, BaniRostam T. PMID: 42597486 [PubMed]
	Diagnosis of syphilitic chorioretinopathy in a patient with a history of relapsing-remitting multiple sclerosis and previous optic neuritis. BMJ Case Rep Kamali Zonouzi S, Micieli J. PMID: 42595385 [PubMed - indexed for MEDLINE]
	Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved Questions. Neurol Ther He J, Blackburn NB, Jokubaitis VG. PMID: 42593635 [PubMed - as supplied by publisher]
	Incidence, Patterns and Predictors of Alemtuzumab-Induced Thyroid Dysfunction in Patients With Multiple Sclerosis: A Northern Ireland Cohort Study. Clin Endocrinol (Oxf) Flynn DO, Kennedy F, Hughes S, Magill F, Mc Donnell GV, Black N, Darrat M, Mullan G, Darcy R, McCance DR, Spence K, Johnston PC. PMID: 42592679 [PubMed - as supplied by publisher]
	Oxidative stress, depressive symptoms, disability, cognitive outcomes and hand dexterity in relapsing-remitting multiple sclerosis patients with mild/moderate disability. IBRO Neurosci Rep Mosaddeghi-Heris R, Taheri N, Talebi M, Naseri A. PMID: 42592261 [PubMed]
	Inter-assay variability in anti-JC virus serology in the era of natalizumab biosimilars: implications for PML risk stratification. Front Immunol Caminero AB, Oreja-Guevara C. PMID: 42592097 [PubMed - indexed for MEDLINE]
	Effectiveness of the recombinant zoster vaccine in adult patients with multiple sclerosis: A claims-based retrospective cohort study in the United States. Mult Scler Kluberg SA, Mayer SE, Spence O, Oraichi D, Seifert H, Ali O, Yun H, Simon AL, Ko JS, Hugh C, Her M, Shattuck K, Jamal-Allial A, Djibo DA, Daniels K, Ma Q, McMahill-Walraven CN, Ogilvie RP, Palmsten K, Selvan M, Ziyadeh NJ, Bhattacharyya S, Ogdie A, George M. PMID: 42590996 [PubMed - as supplied by publisher]
	The Neurovascular Niche: A Gathering Venue for Neuroinflammation and Remyelination in Multiple Sclerosis. Acta Physiol (Oxf) Kazanis I, Silva ME, de la Fuente AG, de Castro F, Rivera FJ. PMID: 42590886 [PubMed - indexed for MEDLINE]
	Mediterranean Diet vs. Time-Restricted Eating: Effects on Circadian Rhythm and Appetite Markers in Female Patients with Multiple Sclerosis-A Pilot Study. Healthcare (Basel) , Çak, , Bayram E, Türker PF. PMID: 42588234 [PubMed]
	Heterogeneity in Teriflunomide Treatment Arms: A Systematic Review and Metaâ€‘Regression of Randomised Multiple Sclerosis Trials. CNS Drugs Bovis F, Signori A, Capanna M, Montobbio N, Sormani MP. PMID: 42587259 [PubMed - as supplied by publisher]
	Prognostic effect of serum glial fibrillary acidic protein and neurofilament light chain for predicting progression independent of relapse activity in multiple sclerosis: A systematic review. Mult Scler Relat Disord Maazi A, Moradi Y. PMID: 42585981 [PubMed - as supplied by publisher]
	Key genetic biomarkers and therapeutic potential in multiple sclerosis: Insights from integrated bioinformatics and mendelian randomization. Comput Biol Chem Xu Z, Xiong K, Zhao D. PMID: 42585774 [PubMed - as supplied by publisher]
	Physical and mental health-related quality of life outcomes of non-pharmacological interventions in early multiple sclerosis: A systematic review and meta-analysis. Clin Rehabil Dawidziuk A, Popiel D. PMID: 42585300 [PubMed - as supplied by publisher]
	Macular Pigment and Retinal Reflectance in a Feasibility Study of Multiple Sclerosis: Toward Novel Biomarkers of Hidden Disease Processes. Invest Ophthalmol Vis Sci Mitchell J, Sloan K, Hogg R, McIlwaine G, Coey R, Steen J, Fitzgerald DC, Moffat J, Hughes S, McDonell G, Peto T, Lengyel I, Csincsik L. PMID: 42584197 [PubMed - indexed for MEDLINE]
	Epitope spreading in multiple sclerosis is shaped by the spatial organisation of immune responses. Front Immunol Rutkowska A. PMID: 42582066 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 44685

Page 1 of 2235



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy